Diagnosis and Classification of Acute Leukemia in Bone Marrow Trephine Biopsies, Utility of a Selected Panel of Minimal Immunohistochemical Markers

  • Priya Subashchandrabose Mail Assistant Professor, Department of Pathology, Saveetha Medical College, Chennai, India
  • Lakshmikanth Ramiah Madanagopaal Chief of Lab and Consultant Pathologist, Department of Pathology, Dr Lal Path Labs, Chennai, India
  • Tadury Madhukar Subba Rao Professor, Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, India
Keywords:
Acute leukemia, Classification, Diagnosis, Immunohistochemistry, Trephine biopsy

Abstract

Background: Acute leukemias are characterized by neoplastic proliferation of hematopoietic stem cells and accumulation of blasts and immature cells in the bone marrow. We applied a selective panel of immunohistochemical markers on bone marrow trephine tissue sections and observed their utility in diagnosis and typing of acute leukemia.

Materials and Methods: The study was done at PSG institute of medical sciences and research from 1st January, 2008 to 30th June, 2012. Immunohistochemistry was done to detect the expression of Myeloperoxidase (MPO), Terminal deoxynucleotidyl transferase (TdT), Cluster of Differentiation 3 (CD3) and Cluster of Differentiation 20 (CD20).

Results: On an average, 76 new cases of leukemia are diagnosed each year in our hospital. Of these 28.7% are acute leukemias, which had a bimodal peak age of occurrence with almost equal sex distribution. Only 9 cases could be typed as Acute Myeloid Leukemia (AML) or Acute Lymphoid Leukemia (ALL) purely by morphology. Another 10 cases were typed using cytochemistry. Immunohistochemical panel helped to type 90% of cases. We also identified 1 case of AML of ambiguous lineage. The data were analysed statistically using SPSS version 21 and found out that the immunohistochemistry was found to be extremely significant (p<001) by Chi-Square test.

Conclusions: Based on our results, we suggest the use of this limited panel of markers for routine evaluation of all acute leukemias. It is easier to type using Immunohistochemistry rather than flowcytometry, given the disadvantage of the costs involved with the latter.

Author Biography

Priya Subashchandrabose, Assistant Professor, Department of Pathology, Saveetha Medical College, Chennai, India
 

References

Catovsky D, Tavares de Castro J. The classification of acute leukemia (AL) and its clinical significance. Schweiz Med Wochenschr. 1983; 113(40):1434-7.

Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classifications of Myeloid Neoplasms and Acute Leukemia: Rationale and Important Changes. Blood. 2009; 114(5):937-51.

Vardiman JW, Harris NL, Brunning RD. The World Health Organization Classification of the Myeloid Neoplasms. Blood. 2002; 100: 2292-302.

Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the Classification of the Acute Leukaemias. FRENCH AMERICAN-BRITISH (FAB) CO-OPERATIVE GROUP. Br J Haematol. 1976; 33(4):451-8.

Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute megakaryoblastic leukemia of megakaryocytic lineage. Ann Intern Med. 1985; 103(3): 460-2.

Bloomfield CD, Brunning RD. FAB M7: Acute Megakaryoblastic Leukemia-Beyond Morphology. Ann Intern Med. 1985; 103(3): 450–2.

Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML–M0). Br J Haematol. 1991; 78(3): 325-29.

D'Costa G, Siddiqui HM, Pradhan RM, et al. Pattern of leukemias: a ten-year incidence study of 242 cases. J Postgrad Med. 1989; 35(4): 191-5.

Murthy NS, Mathew A. Cancer epidemiology, prevention and control. Curr Sci. 2004.86(4): 518-27.

Kusum A, Negi G, Gaur DS, et al. Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India. Indian J Hematol Blood Transfus. 2008; 24(1): 7-11.

Bain BJ. Auer rods or Mc Crae rods? Am J of Hematol. 2011; 86(8): 689.

Loffler H, Gassmann W. Morphology and cytochemistry of acute lymphoblastic leukemia. Baillieres Clin Haematol. 1994; 7(2): 263-72.

Bain BJ. Leukemia diagnosis. 4th ed. Singapore: Wiley–Blackwell. 2010; p. 64-113.

Arber DA, Jenkins KA. Paraffin Section Immunophenotyping of Acute Leukemias in bone marrow specimens. Am J Clin Pathol. 1996; 106: 462–68.

Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Pathobiology. 2007; 74(2):97-114.

Chuang SS, Li CY. Useful Panel of Antibodies for the Classification of Acute Leukemia by Immunohistochemical Methods in Bone Marrow Trephine Biopsy Specimens. Am J Clin Pathol. 1997; 107(4): 410-18.

Olsen RJ, Chang CC, Herrick JL, et al. Acute Leukemia Immunohistochemistry: A Systematic Diagnostic Approach. Arch Pathol Lab Med. 2008; 132(3): 462-75.

Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome. Nature. 2008; 456(7218): 66-72.

Bene MC, Porwit A. Acute leukemias of ambiguous lineage. Semin Diagn Pathol. 2012; 29(1):12-8.

Browman GP, Neame PB, Soamboonsrup P. The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia. Blood. 1986; 68(4): 900-5.

Published
2016-06-28
How to Cite
1.
Subashchandrabose P, Ramiah Madanagopaal L, Subba Rao TM. Diagnosis and Classification of Acute Leukemia in Bone Marrow Trephine Biopsies, Utility of a Selected Panel of Minimal Immunohistochemical Markers. Int J Hematol Oncol Stem Cell Res. 10(3):138-146.
Section
Articles